144 related articles for article (PubMed ID: 32958553)
41. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
[TBL] [Abstract][Full Text] [Related]
42. Primary anaplastic large cell lymphoma in the dura of the brain: case report and prediction of a favorable prognosis.
Kim MK; Cho CH; Sung WJ; Ryoo HM; Lee HJ; Youn SW; Park KK
Int J Clin Exp Pathol; 2013; 6(8):1643-51. PubMed ID: 23923083
[TBL] [Abstract][Full Text] [Related]
43. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
[TBL] [Abstract][Full Text] [Related]
44. Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma.
Yeh KH; Lien HC; Hsu SM; Cheng AL
Am J Hematol; 1999 Feb; 60(2):161-3. PubMed ID: 9929112
[TBL] [Abstract][Full Text] [Related]
45. Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.
Lee T; Park BG; You E; Cho YU; Jang S; Lee SM; Suh C; Park CJ
Ann Lab Med; 2018 Mar; 38(2):172-175. PubMed ID: 29214764
[No Abstract] [Full Text] [Related]
46. Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
Motta G; Vianello F; Menin C; De Nicolo A; Agata S; Altavilla G; Pietrogrande F; Girolami A
Am J Hematol; 2002 Apr; 69(4):272-6. PubMed ID: 11921021
[TBL] [Abstract][Full Text] [Related]
47. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
[TBL] [Abstract][Full Text] [Related]
48. Destructive facial T-cell lymphoma: the difficulty in diagnosis of pyoderma-like processes.
Gibson LE; Hairston BR; Belt RJ; el-Azhary R
Int J Dermatol; 2005 Jul; 44(7):579-83. PubMed ID: 15985028
[No Abstract] [Full Text] [Related]
49. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
[TBL] [Abstract][Full Text] [Related]
50. Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
Chihara D; Fowler NH; Oki Y; Fanale MA; Fayad LE; Westin JR; Hagemeister FB
Br J Haematol; 2017 Dec; 179(5):851-854. PubMed ID: 27502933
[No Abstract] [Full Text] [Related]
51. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma.
Thomas DA; O'Brien S; Cortes J; Giles FJ; Faderl S; Verstovsek S; Ferrajoli A; Koller C; Beran M; Pierce S; Ha CS; Cabanillas F; Keating MJ; Kantarjian H
Blood; 2004 Sep; 104(6):1624-30. PubMed ID: 15178574
[TBL] [Abstract][Full Text] [Related]
52. Angiocentric T-cell lymphoma presenting with multiple cranial nerve palsies and retrobulbar optic neuropathy.
Brazis PW; Menke DM; McLeish WM; Broderick DF; Cheshire WP; Wharen RE; Tiemann M
J Neuroophthalmol; 1995 Sep; 15(3):152-7. PubMed ID: 8574359
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant.
Rongey C; Micallef I; Smyrk T; Murray J
Dig Dis Sci; 2006 Jun; 51(6):1082-6. PubMed ID: 16865575
[No Abstract] [Full Text] [Related]
54. [Carcinomatous meningitis presenting with isolated headache].
Outteryck O; Berteloot D; Senechal O; Fromentin C; Mounier-Vehier F
Rev Neurol (Paris); 2004 Oct; 160(10):949-51. PubMed ID: 15492724
[TBL] [Abstract][Full Text] [Related]
55. Primary leptomeningeal presentation of T-cell lymphoma. Report of a patient and review of the literature.
Marsh WL; Stevenson DR; Long HJ
Cancer; 1983 Mar; 51(6):1125-31. PubMed ID: 6336987
[TBL] [Abstract][Full Text] [Related]
56. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
[TBL] [Abstract][Full Text] [Related]
57. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
Jabbour E; O'Brien S; Kantarjian H; Garcia-Manero G; Ferrajoli A; Ravandi F; Cabanillas M; Thomas DA
Blood; 2007 Apr; 109(8):3214-8. PubMed ID: 17209054
[TBL] [Abstract][Full Text] [Related]
58. [A case of leptomeningeal melanomatosis presenting with right abducens nerve palsy].
Nakaoku Y; Murakami G; Fujimoto Y; Shirase T; Imamine R; Mitsueda-Ono T; Matsui M
Rinsho Shinkeigaku; 2014; 54(8):675-8. PubMed ID: 25142543
[TBL] [Abstract][Full Text] [Related]
59. Primary leptomeningeal melanocytosis presenting as chronic meningitis.
Honigberg MC; Papavassiliou E; Cohen YZ
J Clin Neurosci; 2014 Jun; 21(6):1056-8. PubMed ID: 24355206
[TBL] [Abstract][Full Text] [Related]
60. Hematologic neoplasia and the central nervous system.
Sham RL; Phatak PD; Kouides PA; Janas JA; Marder VJ
Am J Hematol; 1999 Dec; 62(4):234-8. PubMed ID: 10589079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
